bupropion
- Product NDC
- 70518-2641
- 11-digit product format
- 705182641
- Labeler code
- 70518
- Product ID
- 70518-2641_de45f01a-4626-3aad-e053-2a95a90a405a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA202304
- Marketing category
- ANDA
- Marketing start
- 2020-03-24
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-2641 | BUPROPION (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] | 7 | Legacy NDC | 20250326_57010a66-792b-408b-929b-5a7d1ae76756.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2641-0 | 70518264100 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2641-0) | 2020-03-24 | 0000-00-00 | No | No | Current |